Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2003
11/20/2003WO2003095982A1 Wavy interface mixer
11/20/2003WO2003095449A1 Small molecules for inhibition of function and drug delivery to leukocytes
11/20/2003WO2003095431A1 Heterocyclic amine diol compounds and their biocidal derivatives
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094854A2 Succinoyl aminopyrazoles and related compounds
11/20/2003WO2003050062A3 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003014079A8 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
11/20/2003US20030216583 Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
11/20/2003US20030216581 Textile grafted with bactericide
11/20/2003US20030216577 Catalytic ozonolysis using transition metal catalys
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362840A1 Process for the preparation of aromatic and heteroaromatic carboxylic acids via catalytic ozonolysis
11/19/2003EP1362038A1 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
11/19/2003EP1362037A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
11/19/2003EP1361851A1 Primary intermediates for oxidative coloration of hair
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
11/19/2003EP1095024B1 Method for producing carbonyl diimidazoles
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0863880B1 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/18/2003US6649717 Stabilized composition of O- and N-vinyl compounds and use of ammonium salts as stabilizers
11/18/2003US6649691 Wet adhesion monomer and derived copolymers for latex paints
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649613 Diacylhydrazine derivatives
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/15/2003CA2430171A1 Preparation of aromatic and heteroaromatic carboxylic acids by catalytic ozonolysis
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093263A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093246A1 Ionic liquids
11/13/2003WO2003093243A1 Preparations for the topical application of anti-androgenically active substances
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093220A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030211323 Such as larger particle sized bromochlorodimethylhydantoin
11/13/2003CA2485093A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2483830A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003CA2483829A1 Ionic liquids
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361246A1 Organic polymer and novel polymerizable compound
11/12/2003EP1361217A1 4-Thionoimidazolidine derivatives as oil-soluble additives for lubricating oils
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360179A2 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin
11/12/2003EP1359892A1 Primary intermediates for oxidative coloration of hair
11/12/2003EP1200412B1 Imidazole antiproliferative agents
11/12/2003EP0925283B1 Novel polymerizable acyl imidazolidinone monomers
11/12/2003CN1455772A Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645401 Conjugated copolymers of dithienothiophene with vinylene or acetylene
11/11/2003US6645259 Cationic aminoanthraquinones, their use for dyeing keratinous fibers, dyeing compositions containing them and methods of dyeing
11/11/2003CA2055637C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091222A1 Process for producing n-alkyl-n'-alkylimidazolium salt
11/06/2003WO2003091211A1 Novel heteroaryl compounds
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003US20030208083 Amino acid derivatives and methods of making the same
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207896 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/06/2003US20030207889 Metaloenzyme and tumor necrosis factor-alpha converting enzyme inhibitors such as 2-(4-Methoxyphenylsulfonylmethyl)-5-phthalimido-pentanoic acid N-hydroxy amide, used for prophylaxis of degenerative diseases and cancer
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207400 Double stranded DNA of target sequence(s) bound non-covalently to a sequence specific polyamide (SSP) moiety having a ligand moiety linked covalently to said polyamide; polyamide contains N-methylpyrrole or N-methylimidazole groups
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 345